Skip to main content

Accessibility

Accessible information is part of reliable infrastructure

NEUVIOR aims to make its digital information understandable, navigable and usable across devices and access needs, while treating accessibility as continuous work.

Approach | Accessibility by designStatus | Continuous review and improvementFeedback | Barriers should be reported

Accessibility approach

Design for clear reading, navigation and interaction.

Content should use meaningful headings, readable language, sufficient contrast, keyboard accessible controls and alternatives for important visual information.

No single statement should imply permanent compliance across every page, browser, device and assistive technology.

01

Understandable

Use plain structure, concise copy and visible status language.

02

Navigable

Support keyboard use, predictable focus and descriptive link text.

03

Perceivable

Provide contrast, scalable text and alternatives for meaningful visuals.

Motion and media

Advanced interaction must not block access.

Animation should support hierarchy and explanation. The experience should respect reduced motion preferences and retain access to the same information without motion.

01

Reduced motion

Remove non essential movement when the user requests it.

02

Static meaning

Ensure a diagram’s information remains available without animation.

03

Interaction safety

Avoid controls that depend only on hover, colour or precise pointer movement.

Feedback cycle

Report, assess, repair and verify.

A useful accessibility report identifies the page, task, device or assistive technology and the barrier encountered. Do not include sensitive personal or health information.

01

Report

Describe the route and the task that could not be completed.

02

Assess

Reproduce the barrier and identify its user impact.

03

Repair

Apply the smallest durable fix that preserves access across the interface.

04

Verify

Retest the affected task with relevant access methods.

Accessibility

Tell us what would make this experience more usable.

Describe the practical barrier without including medical records, diagnostic information or data that identifies patients.

No data that identifies patients
No confidential clinical records
Human response only

If the form cannot be sent, email [email protected].

Make the next step useful

Bring the problem that needs a clearer decision.

Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01What is NEUVIOR?

NEUVIOR is a pharmaceutical company registered in Scotland. It is building capabilities across medicines intelligence, governed technology and longer term development. PHARMORIS is its immediate product priority.

02What does NEUVIOR build today?

NEUVIOR is developing PHARMORIS, a human-governed medicines operations system in controlled, non-production development. It is intended to connect evidence, decisions, accountable work and value review. No independent TRL, deployment, customer adoption or clinical validation is claimed.

03What is PHARMORIS by NEUVIOR?

PHARMORIS is a configurable medicines operations system under controlled development. It is designed to help authorised teams progress medicine opportunities from evidence linked to its source, through an owned ActionCase, a human decision, delivery and review.

04Who founded NEUVIOR?

Varun Sharma is the Founder, CEO and CTO of NEUVIOR and leads the company and PHARMORIS product architecture.

05Where does NEUVIOR have a presence?

NEUVIOR works across Glasgow, London and Mumbai. Glasgow is the company origin and registered Scottish base. London supports commercial activity led by the founder. Mumbai supports market engagement in India and relationships across the pharmaceutical sector. These are different forms of presence. They do not imply three registered offices or regulated facilities.